Genix Pharmaceuticals Corp
XTSX:GENX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zhejiang JIULI Hi-tech Metals Co Ltd
SZSE:002318
|
CN |
|
K
|
Kreate Group Oyj
OMXH:KREATE
|
FI |
|
Byke Hospitality Ltd
NSE:BYKE
|
IN |
|
S
|
SOM Distilleries and Breweries Ltd
BSE:507514
|
IN |
|
F
|
Fiskars Oyj Abp
OMXH:FSKRS
|
FI |
Genix Pharmaceuticals Corp
Long-Term Debt
Genix Pharmaceuticals Corp
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
Long-Term Debt
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Flora Growth Corp
NASDAQ:FLGC
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitality Products Inc
XTSX:VPI
|
Long-Term Debt
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jamieson Wellness Inc
TSX:JWEL
|
Long-Term Debt
CA$441.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
L
|
Leef Brands Inc
CNSX:LEEF
|
Long-Term Debt
$21m
|
CAGR 3-Years
38%
|
CAGR 5-Years
98%
|
CAGR 10-Years
N/A
|
|
Genix Pharmaceuticals Corp
Glance View
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm focused on developing and licensing novels and products for sales through retail outlets and well as direct to consumers and e-commerce platforms. The firm holds licensing agreement for a range of products, including 30 Ophthalmic drugs, Sucanon, Renochlor, Flu-X, and Levothyroxine sodium (generic Synthroid). Flu-X anti-viral spray is an herbal, oral, anti-viral, anti-flu and anti-cold virus spray. Renochlor is an aid in the restoration of kidney health and kidney function. Sucanon is a natural substitute for prescription pharmaceuticals for non-insulin dependent diabetes patients.
See Also
What is Genix Pharmaceuticals Corp's Long-Term Debt?
Long-Term Debt
0
CAD
Based on the financial report for Oct 31, 2025, Genix Pharmaceuticals Corp's Long-Term Debt amounts to 0 CAD.